Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000922423-97-000243
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
17
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMMENDMENT NO. 1 TO ANNUAL REPORT 10-K/A 290887
2 EXECUTIVE COMPENSATION AGREEMENT EX-10.86 22939
3 COLLABORATION AGREEMENT EX-10.87 16531
4 ASSIGNMENT AGREEMENT EX-10.88 27091
5 DEVELOPMENT AND MARKETING AGREEMENT EX-10.89 264680
6 LICENSE AGREEMENT EX-10.90 204176
7 OPTION, DEVELOPMENT & SUB-LICENSE AGREEMENT EX-10.91 96166
8 DEVELOPMENT & SUB-LICENSE AGREEMENT EX-10.92 104207
9 DEVELOPMENT & SUB-LICENSE AGREEMENT EX-10.93 102514
10 DEVELOPMENT & SUB-LICENSE AGREEMENT/DICLOFENAC EX-10.94 102780
11 DEVELOPMENT & SUB-LICENSE AGREEMENT EX-10.95 98474
12 DEVELOPMENT & SUB-LICENSE AGREEMENT EX-10.96 104505
13 LICENSE TERMINATION AGREEMENT EX-10.97 5428
14 ACCURATE TRANSLATION CERTIFICATION EX-10.98 1544
15 SUBSIDIARIES OF THE REGISTRANT EX-22.1 374
16 CONSENT OF AUDITORS EX-23.1 729
17 FDS EX-27 2130
  Complete submission text file 0000922423-97-000243.txt   1448354
Mailing Address 3550 GENERAL ATOMICS COURT SAN DIEGO CA 92121
Business Address 3550 GENERAL ATOMICS COURT SAN DIEGO CA 92121 6194552700
GENTA INCORPORATED /DE/ (Filer) CIK: 0000880643 (see all company filings)

EIN.: 330326866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19635 | Film No.: 97572006
SIC: 2836 Biological Products, (No Diagnostic Substances)